NISHA KEELER: Open Payments
NPI 1083121933 · GAHANNA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,341 in 49 payments from 12 companies in 2025. Trend: 2023 $846 · 2024 $1,999 · 2025 $1,341
Food & beverage: $1,341
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 23 | $678 |
| PFIZER INC. | 4 | $161 |
| Endo USA, Inc. | 5 | $96 |
| COLOPLAST CORP | 1 | $87 |
| Janssen Biotech, Inc. | 5 | $80 |
| PROGENICS PHARMACEUTICALS, INC. | 3 | $74 |
| IMMUNITYBIO, INC. | 3 | $64 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| ABBVIE INC. | 1 | $25 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
Products named: GEMTESA, XTANDI, ORGOVYX, Luja Coude, ERLEADA, AVEED, PYLARIFY, ANKTIVA.
Industry payments across OH — which companies pay providers there.
